BBVA
DGX icon

Banco Bilbao Vizcaya Argentaria’s Quest Diagnostics DGX Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55M Sell
21,460
-58
-0.3% -$11.4K 0.03% 304
2026
Q1 		$4.22M Sell
21,518
-348
-2% -$67.6K 0.03% 310
2025
Q4 		$3.79M Sell
21,866
-831
-4% -$151K 0.03% 330
2025
Q3 		$4.33M Buy
22,697
+910
+4% +$161K 0.03% 300
2025
Q2 		$3.91M Sell
21,787
-537
-2% -$93.3K 0.04% 302
2025
Q1 		$3.78M Buy
22,324
+790
+4% +$130K 0.04% 304
2024
Q4 		$3.25M Sell
21,534
-731
-3% -$114K 0.03% 332
2024
Q3 		$3.46M Buy
22,265
+345
+2% +$51.5K 0.03% 340
2024
Q2 		$3M Buy
21,920
+124
+0.6% +$17K 0.03% 360
2024
Q1 		$2.9M Sell
21,796
-25,706
-54% -$3.34M 0.03% 372
2023
Q4 		$6.55M Sell
47,502
-877
-2% -$115K 0.08% 236
2023
Q3 		$5.9M Sell
48,379
-574
-1% -$76.5K 0.08% 242
2023
Q2 		$6.88M Sell
48,953
-947
-2% -$131K 0.09% 221
2023
Q1 		$7.06M Buy
49,900
+1,365
+3% +$195K 0.09% 219
2022
Q4 		$7.59M Buy
48,535
+1,671
+4% +$240K 0.11% 208
2022
Q3 		$5.75M Sell
46,864
-706
-1% -$93K 0.09% 211
2022
Q2 		$6.33M Sell
47,570
-1,294
-3% -$176K 0.1% 208
2022
Q1 		$6.64M Buy
48,864
+12,090
+33% +$1.69M 0.09% 207
2021
Q4 		$6.3M Buy
36,774
+13,754
+60% +$2.09M 0.08% 214
2021
Q3 		$3.35M Buy
23,020
+19,569
+567% +$2.86M 0.05% 278
2021
Q2 		$455K Sell
3,451
-12,746
-79% -$1.67M 0.01% 635
2021
Q1 		$2.08M Buy
16,197
+6,487
+67% +$799K 0.04% 342
2020
Q4 		$1.16M Buy
9,710
+208
+2% +$25.4K 0.03% 444
2020
Q3 		$1.09M Sell
9,502
-5,059
-35% -$598K 0.03% 394
2020
Q2 		$1.66M Sell
14,561
-1,917
-12% -$203K 0.05% 271
2020
Q1 		$1.32M Buy
16,478
+2,136
+15% +$221K 0.05% 315
2019
Q4 		$1.53M Buy
+14,342
New +$1.5M 0.05% 347

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's DGX Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria reduced its Quest Diagnostics (DGX) stake by 0.27% in Q2 2026, selling an estimated $11.4K and leaving 21,460 shares worth $4.55M. The position accounts for 0.03% of the portfolio, ranked #304.

Banco Bilbao Vizcaya Argentaria first reported a position in DGX in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.59M in Q4 2022. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Banco Bilbao Vizcaya Argentaria held 21,460 shares of Quest Diagnostics worth $4.55M as of Q2 2026.
  • Banco Bilbao Vizcaya Argentaria sold 58 Quest Diagnostics shares in Q2 2026, an estimated $11.4K.
  • Quest Diagnostics made up 0.03% of Banco Bilbao Vizcaya Argentaria's portfolio in Q2 2026, its #304 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Quest Diagnostics in Q4 2019 and has held it in 27 quarters since.
  • Banco Bilbao Vizcaya Argentaria's Quest Diagnostics position peaked at $7.59M in Q4 2022.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.